Methyl 2-(5-(trifluoromethyl)pyridin-2-yl)acetate, 97.0%, 100mg

3-(BICYCLO[1.1.1]PENTAN-1-YL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOIC ACID, 250mg

5-Phenyloxazole>95.0%(GC)1g

1,1-Dimethylethyl 4-(ethoxycarbonyl)benzeneacetate, 100mg

Butanoic acid, 3-methyl-2-[[[(phenylmethoxy)carbonyl]amino]methyl]-, (2R)-, 96%, 100mg

3-Chloro-2-(chloromethyl)pyridine, 95.0%, 100mg

(S)-Methyl 2-acetamido-5-guanidinopentanoate hydrochloride, 95.0%, 250mg

Hydroxyde de sodium, min 98%, pa, ISO, en pastilles, 10 kg, emballage plastique.

3-Aminohexanoic acid, 97%, 1g

3-(3-methylphenyl)-2'-thiomethylpropiophenone, 97.0%, 1g

4-(3-Bromophenyl)dibenzo[b,d]thiophene, 99%, 1g

3,4-Dimethoxybenzenesulfonamide, 98.0%, 5g

(Diethoxyphosphoryl)methyl 4-methylbenzenesulfonate, 97.0%, 100g